Skip to content

First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505030-99-00
Acronym
RT-IS-G-H-2301
Enrollment
36
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder (PTSD)

Interventions

None listed

Sponsors

Rest Therapeutics
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026